Across tumor types, 1-year NGS uptake rose substantially from 2018 to 2022, reaching 74.5% in aNSCLC and 78.1% in mCRC, but remaining ~25% in mBC/mPC overall. Median time-to-NGS differed markedly by ...

K-Electric (KE), the sole power utility of Karachi, has appointed Syed Taha as the company’s new chief executive officer (CEO). The listed company shared the development in a notice to the Pakistan ...

Good morning, ladies and gentlemen, and welcome to the Natural Gas Services Group, Inc. Quarter 4 Earnings Call. [Operator Instructions]. I would now like to turn the call over to Ms. Anna Delgado.

Natural Gas Services (NGS) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.29 per share a year ago. These ...

Your browser does not support the audio element. In my January 2026 GPS World newsletter, I noted that the National Geodetic Survey (NGS) convened the Federal ...

This study evaluates inclusion of National Comprehensive Cancer Network (NCCN) guideline recommended biomarkers for metastatic non–small cell lung cancer (NSCLC) in commercially available targeted ...

Character customization has become a bullet point for most modern games, and for good reason. Player expression is one of the strongest ways to capture interest in the long term. Usually, though, it’s ...

SEGA held a new NGS Headline livestream this past week for Phantasy Star Online 2 New Genesis, as we got a taste of what's coming throughout February 2026. The shorthand is that players will see the ...

TULSA, Okla. — Two separate billing problems at Public Service Company of Oklahoma caused confusion and frustration for customers, including one that left over 1,300 people without electricity during ...

Phantasy Star Online 2: New Genesis is the ultimate PSO2 experience in which the time-tested elements are kept intact, while the game design, gameplay and graphics engine will be completely redesigned ...

Hello. This is Mark Kris, from Sloan Kettering, continuing my discussion about the increasing precision of lung cancer therapies and the need for additional testing beyond our routine next-generation ...